Cargando…
New Approaches to Filling the Gap in Tuberculosis Drug Discovery
For the first time in decades, say the authors, there is a tuberculosis drug pipeline, but the paucity of candidates is still cause for alarm.
Autores principales: | Casenghi, Martina, Cole, Stewart T, Nathan, Carl F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062479/ https://www.ncbi.nlm.nih.gov/pubmed/17988169 http://dx.doi.org/10.1371/journal.pmed.0040293 |
Ejemplares similares
-
Closing the Policy-Practice Gap in the Management of Child Contacts of Tuberculosis Cases in Developing Countries
por: Hill, Philip C., et al.
Publicado: (2011) -
A New Approach to Psychiatric Drug Approval in Europe
por: Barbui, Corrado, et al.
Publicado: (2013) -
Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries
por: Schluger, Neil, et al.
Publicado: (2007) -
Future directions for HIV service delivery research: Research gaps identified through WHO guideline development
por: Ford, Nathan, et al.
Publicado: (2021) -
New era of drug innovation in China
por: Ye, Xuan, et al.
Publicado: (2019)